Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)

SHA:600488 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	738.84	638.46	718.86	647.74	232.22	244.37
Cash & Short-Term Investments	738.84	638.46	718.86	647.74	232.22	244.37
Cash Growth	2.48%	-11.18%	10.98%	178.94%	-4.97%	-3.10%
Accounts Receivable	591.56	459.12	578.33	498.17	596.38	475.05
Other Receivables	30.47	25.21	30.8	27.09	30.75	28.51
Receivables	622.04	484.33	609.13	525.26	627.13	503.56
Inventory	665.06	651.92	725.58	1,158	975.64	1,105
Other Current Assets	25.3	29.76	54.5	29.96	47.58	33.81
Total Current Assets	2,051	1,804	2,108	2,360	1,883	1,886
Property, Plant & Equipment	2,807	2,875	3,069	3,174	3,348	3,226
Long-Term Investments	228.05	227.88	164.2	307.15	360.64	403.24
Other Intangible Assets	349.96	349.66	303.66	254.61	192.38	119.98
Long-Term Deferred Tax Assets	28.1	28.88	41.81	40.38	32.1	34.98
Long-Term Deferred Charges	183.91	180.91	168.41	175.11	150.97	133.98
Other Long-Term Assets	229.38	231.49	287.15	338.69	378.31	370.97
Total Assets	5,878	5,698	6,142	6,651	6,345	6,176
Accounts Payable	725.32	638.69	719.55	792.9	565.94	592.17
Accrued Expenses	74.58	184.16	161.15	84.33	64.77	40.01
Short-Term Debt	125.71	108.58	270.25	648.34	588.63	830.56
Current Portion of Long-Term Debt	7.99	0.54	404.59	295.83	421.09	-
Current Portion of Leases	-	0.17	0.11	0.38	30.27	-
Current Income Taxes Payable	18.33	0.87	0.85	1.65	16.7	6.04
Current Unearned Revenue	45.43	79.73	137.19	134.11	68.35	25.94
Other Current Liabilities	210.63	202.27	246.6	322.55	267.8	310.72
Total Current Liabilities	1,208	1,215	1,940	2,280	2,024	1,805
Long-Term Debt	537.36	424.6	277	458.64	367.24	402.36
Long-Term Leases	0.07	0.11	-	0.12	0.27	50
Long-Term Unearned Revenue	137.46	140.83	144.99	117.7	89.56	91.7
Long-Term Deferred Tax Liabilities	27.78	27.96	18.12	39.3	47.53	53.96
Other Long-Term Liabilities	0.48	3.92	8.77	1.01	-	-
Total Liabilities	1,915	1,812	2,389	2,897	2,528	2,403
Common Stock	1,092	1,092	1,094	1,096	1,100	1,101
Additional Paid-In Capital	320.48	320.32	322.19	327.1	335.01	335.49
Retained Earnings	1,592	1,534	1,495	1,389	1,369	1,331
Treasury Stock	-	-	-4.73	-10.34	-18.85	-20.56
Comprehensive Income & Other	113.4	111.41	46.95	170.35	207.88	244.53
Total Common Equity	3,118	3,057	2,954	2,973	2,993	2,992
Minority Interest	845.93	828.52	799.75	781.33	823.83	781.07
Shareholders' Equity	3,963	3,886	3,753	3,754	3,817	3,773
Total Liabilities & Equity	5,878	5,698	6,142	6,651	6,345	6,176
Total Debt	671.13	533.99	951.96	1,403	1,407	1,283
Net Cash (Debt)	67.71	104.46	-233.1	-755.57	-1,175	-1,039
Net Cash Per Share	0.06	0.10	-0.21	-0.68	-1.09	-0.95
Filing Date Shares Outstanding	1,092	1,092	1,094	1,096	1,100	1,101
Total Common Shares Outstanding	1,092	1,092	1,094	1,096	1,100	1,101
Working Capital	843.24	589.46	167.77	80.39	-140.98	81.03
Book Value Per Share	2.86	2.80	2.70	2.71	2.72	2.72
Tangible Book Value	2,768	2,708	2,650	2,718	2,801	2,872
Tangible Book Value Per Share	2.53	2.48	2.42	2.48	2.55	2.61
Buildings	-	2,290	2,277	2,198	1,792	1,739
Machinery	-	2,549	2,541	2,405	2,149	1,951
Construction In Progress	-	44.52	34.44	126.71	544.34	494.6

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.